Enable job alerts via email!
Clinical Research Fellow in Translational Oncology
UCL
London
On-site
GBP 40,000 - 60,000
Full time
Today
Be an early applicant
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
Start fresh or import an existing resume
Job summary
Join UCL's Treatment Resistance Team at the forefront of oncology research. This role involves coordinating critical data collection and analysis for the ReIMAGINE study, contributing to advancements in understanding cancer treatment resistance. Ideal for medical trainees pursuing a career in oncology or related fields, offering strong mentorship and professional development.
Benefits
41 Days holiday (including annual leave and bank holidays)
Defined benefit pension scheme (CARE)
Cycle to work scheme
On-site nursery
On-site gym
Enhanced maternity, paternity and adoption pay
Employee assistance programme
Discounted medical insurance
Qualifications
- Eligible for full GMC Registration.
- Prior experience in clinical data collection and curation is desirable.
Responsibilities
- Coordinate the collection and analysis of clinical, imaging, and biopsy data.
- Hold honorary contracts across various ReIMAGINE sites.
Skills
Good Clinical Practice training
Supervision of junior staff
Clinical data interpretation
Education
Undergraduate medical degree (MBBS or equivalent)
Completion of UK Foundation Training
Job description
About us
The UCL Cancer Institute ( https://www.ucl.ac.uk/cancer/ ) is a state-of-the-art institute to consolidate cancer research at UCL and promote links with our partner teaching hospitals, in order to support excellence in basic and translational studies. The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically-led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education and world-class research.
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
About the role
The main objective of this post will be to coordinate the collection, processing, and analysis of clinical, imaging and biopsy data from the ReIMAGINE study. As such, the postholder will hold honorary contracts across all ReIMAGINE sites (University College London Hospital, the Royal Free Hospital and Charing Cross Hospital). Overall responsibility for the postholder will be with the UCL Treatment Resistance Team. This appointment would suit foundation, core medical or core surgical trainees considering a career in oncology, urology, radiology or pathology or specialist trainees prior to undertaking a MD/PhD. We have a strong track record in helping trainees gain their subsequent chosen positions including national training numbers, consultant posts and industry roles. The post will be appointed on one of the scales including in the job description, depending on experience and is available for one year in the first instance.
The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
Prospective candidates are encouraged to visit the UCLH and UCL Cancer Institute websites or premises. Further information can be obtained from Dr Vasilis Stavrinides ( v.stavrinides@ucl.ac.uk ) or Dr Matt Fittall ( matthew.fittall@ucl.ac.uk ).
About you
Successful candidate must have Undergraduate medical degree (MBBS or equivalent), completion of UK Foundation Training (or equivalent) and be eligible for full GMC Registration. Evidence of Good Clinical Practice training (or equivalent) is essential as is the ability to supervise junior staff and provide training as necessary. Prior experience in collecting, curating and interpreting clinical data would be desirable.
What we offer
As well as the exciting opportunities this role presents we also offer some great benefits some of which are below
https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits
Our commitment to Equality, Diversity and Inclusion
As London's Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world's talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL's workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.
You can read more about our commitment to Equality, Diversity and Inclusion here https://www.ucl.ac.uk/equality-diversity-inclusion/
The UCL Cancer Institute ( https://www.ucl.ac.uk/cancer/ ) is a state-of-the-art institute to consolidate cancer research at UCL and promote links with our partner teaching hospitals, in order to support excellence in basic and translational studies. The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically-led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education and world-class research.
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
About the role
The main objective of this post will be to coordinate the collection, processing, and analysis of clinical, imaging and biopsy data from the ReIMAGINE study. As such, the postholder will hold honorary contracts across all ReIMAGINE sites (University College London Hospital, the Royal Free Hospital and Charing Cross Hospital). Overall responsibility for the postholder will be with the UCL Treatment Resistance Team. This appointment would suit foundation, core medical or core surgical trainees considering a career in oncology, urology, radiology or pathology or specialist trainees prior to undertaking a MD/PhD. We have a strong track record in helping trainees gain their subsequent chosen positions including national training numbers, consultant posts and industry roles. The post will be appointed on one of the scales including in the job description, depending on experience and is available for one year in the first instance.
The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
Prospective candidates are encouraged to visit the UCLH and UCL Cancer Institute websites or premises. Further information can be obtained from Dr Vasilis Stavrinides ( v.stavrinides@ucl.ac.uk ) or Dr Matt Fittall ( matthew.fittall@ucl.ac.uk ).
About you
Successful candidate must have Undergraduate medical degree (MBBS or equivalent), completion of UK Foundation Training (or equivalent) and be eligible for full GMC Registration. Evidence of Good Clinical Practice training (or equivalent) is essential as is the ability to supervise junior staff and provide training as necessary. Prior experience in collecting, curating and interpreting clinical data would be desirable.
What we offer
As well as the exciting opportunities this role presents we also offer some great benefits some of which are below
- 41 Days holiday (including 27 days annual leave 8 bank holiday and 6 closure days)
- Defined benefit career average revalued earnings pension scheme (CARE)
- Cycle to work scheme and season ticket loan
- On-Site nursery
- On-site gym Enhanced maternity, paternity and adoption pay
- Employee assistance programme
- Staff Support Service Discounted medical insurance
https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits
Our commitment to Equality, Diversity and Inclusion
As London's Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world's talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL's workforce. These include people from Black, Asian and ethnic minority backgrounds; disabled people; LGBTQI+ people; and for our Grade 9 and 10 roles, women.
You can read more about our commitment to Equality, Diversity and Inclusion here https://www.ucl.ac.uk/equality-diversity-inclusion/
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
Land a better
job faster
job faster
Follow us
